Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)

Clinical trial NCT00105157 · COMPLETED

Trial details

NCT number: NCT00105157
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Infections Acquired Immunodeficiency Syndrome

Start date: 2005-03-01
Primary completion: 2006-10-01
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.